The Food and Drug Administration’s Clinical Decision Support (CDS) Software guidance published 18 September 2022 violated procedural law and should be rescinded, said CDS Coalition legal counsel Bradley Thompson.
The
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?